Simulations Plus Inc (SLP)

8.82
0.06 0.68
NASDAQ : Technology
Prev Close 8.76
Open 8.60
Day Low/High 8.55 / 8.93
52 Wk Low/High 6.08 / 11.89
Volume 62.47K
Avg Volume 25.60K
Exchange NASDAQ
Shares Outstanding 17.05M
Market Cap 151.08M
EPS 0.20
P/E Ratio 32.81
Div & Yield 0.20 (2.30%)

Latest News

Simulations Plus Releases PKPlus™ Version 1.0

Simulations Plus Releases PKPlus™ Version 1.0

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released version 1.

Simulations Plus Releases ADMET Predictor™ Version 8.0

Simulations Plus Releases ADMET Predictor™ Version 8.0

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released Version 8.

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly...

Simulations Plus Reports Third Quarter FY2016 Financial Results

Simulations Plus Reports Third Quarter FY2016 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...

Simulations Plus Sets Date For 3rd Quarter 2016 Earnings Release And Conference Call

Simulations Plus Sets Date For 3rd Quarter 2016 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the third quarter of its 2016 fiscal year on Thursday, July 14, 2016.

Oversold Conditions For Simulations Plus (SLP)

Oversold Conditions For Simulations Plus (SLP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Simulations Plus Reports Preliminary Revenues For Third Quarter FY2016

Simulations Plus Reports Preliminary Revenues For Third Quarter FY2016

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the third quarter of its fiscal year 2016,...

Simulations Plus To Present At LD Micro Invitational On June 7, 2016

Simulations Plus To Present At LD Micro Invitational On June 7, 2016

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development, announced that Walt Woltosz, chief executive...

Simulations Plus Enters Oversold Territory (SLP)

Simulations Plus Enters Oversold Territory (SLP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Simulations Plus About To Put More Money In Your Pocket (SLP)

Simulations Plus About To Put More Money In Your Pocket (SLP)

Looking at the universe of stocks we cover at Dividend Channel, on 4/28/16, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 5/9/16.

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly...

Simulations Plus Releases DDDPlus Version 5.0

Simulations Plus Releases DDDPlus Version 5.0

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released Version 5.

Simulations Plus Reports Second Quarter FY2016 Financial Results

Simulations Plus Reports Second Quarter FY2016 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development from the earliest discovery through all...

Simulations Plus Sets Date For 2nd Quarter 2016 Earnings Release And Conference Call

Simulations Plus Sets Date For 2nd Quarter 2016 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the second quarter of its 2016 fiscal year on Wednesday, April 13, 2016.

Simulations Plus Signs 5-year Consulting Agreement With Major Research Foundation

Simulations Plus Signs 5-year Consulting Agreement With Major Research Foundation

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation software for pharmaceutical discovery and development, today announced that it has been awarded a $4.

Oversold Conditions For Simulations Plus (SLP)

Oversold Conditions For Simulations Plus (SLP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Simulations Plus Releases KIWI Version 1.5

Simulations Plus Releases KIWI Version 1.5

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its Buffalo division (Cognigen Corporation) has released...

Simulations Plus Reports Record Preliminary Revenues For Second Quarter FY2016

Simulations Plus Reports Record Preliminary Revenues For Second Quarter FY2016

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the second quarter of its fiscal year 2016,...

Simulations Plus To Present At Source Capital Group's 2016 Disruptive Growth & Healthcare Conference

Simulations Plus To Present At Source Capital Group's 2016 Disruptive Growth & Healthcare Conference

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that Walt Woltosz, Chairman and Chief Executive Officer, will...

SLP Ex-Dividend Reminder - 1/27/16

SLP Ex-Dividend Reminder - 1/27/16

Looking at the universe of stocks we cover at Dividend Channel, on 1/27/16, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 2/5/16.

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly...

Simulations Plus Reports First Quarter FY2016 Financial Results

Simulations Plus Reports First Quarter FY2016 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development from the earliest discovery through all...

Simulations Plus Sets Date For 1st Quarter 2016 Earnings Release And Conference Call

Simulations Plus Sets Date For 1st Quarter 2016 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its quarterly report on Form 10-Q for...

Simulations Plus Reports Record Preliminary Revenues For First Quarter FY2016

Simulations Plus Reports Record Preliminary Revenues For First Quarter FY2016

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the first quarter of its fiscal year 2016,...

Simulations Plus To Present At Two Upcoming Investor Conferences

Simulations Plus To Present At Two Upcoming Investor Conferences

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today announced that John DiBella ,Vice President of Marketing and Sales, will present at the LD Micro...

10 High-Growth Health Care Stocks to Buy Now

10 High-Growth Health Care Stocks to Buy Now

Which health care stocks are both alluring - when it comes to rapid advances in new technology or a cure for a disease - but also sound investments?

Simulations Plus Reports FY2015 And Fourth Quarter FY2015 Financial Results

Simulations Plus Reports FY2015 And Fourth Quarter FY2015 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2015 fiscal year (FY15) and fourth quarter (4Q15) ended August...

Simulations Plus Sets Date For 4th Quarter And Fiscal Year 2015 Earnings Release And Conference Call

Simulations Plus Sets Date For 4th Quarter And Fiscal Year 2015 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its annual report on Form 10-K for the...